STAT3 and hepatocellular carcinoma: Recently, Hou et al. found that ER-α could suppress STAT3 activity in HCC cell lines and tumour tissues by elevating the expression of protein tyrosine phosphatase receptor type O (PTPRO) in female mice [80].